Haneen Shalabi

Jul 3, 2024 | onlinelibrary.wiley.com | Tatiana C. Coverdell |Haneen Shalabi |Nirali Shah |Roa Harb

CAR chimeric antigen receptor CRS cytokine release syndrome ICU intensive care unit IEC-HS immune effector cell-associated hemophagocytic lymphohistiocytosis-like syndrome 1 INTRODUCTION Chimeric antigen receptor (CAR) T-cell therapy is associated with a host of inflammatory conditions, including cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and the more recently described immune effector cell-associated hemophagocytic...